Federal and Regulatory Outreach

AMRPA Response to Medicare Advantage Part C Proposed Rule for FY 2021 and 2022

April 6, 2020
Medicare Advantage Prior Authorization

Letter to HHS & CMS Administrators Regarding COVID-19

March 13, 2020
COVID-19

AMRPA Response to U.S. News Proposed 2020-2021 Rehabilitation Hospital Ranking Methodology

March 10, 2020
Rehab Rankings

AMRPA Responds to CMS: Advance Notice of Methodological Changes for Calendar Year (CY) 2021 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies – Part II

March 6, 2020
Medicare Advantage Prior Authorization Regulatory

AMRPA Statement on Fiscal Year 2021 HHS Budget Proposal

February 25, 2020
Burden Reduction Medicare Advantage Prior Authorization

AMRPA Responds to Proposed Rules on Anti-Kickback Statute and Physician Self-Referral Regulations

December 31, 2019
Regulatory

AMRPA Response to Rural & Underserved Communities Task Force RFI

November 29, 2019
Legislative Medicare Advantage Prior Authorization Telehealth

AMRPA Opposes Recently Finalized Hospital Pricing Regulations

November 26, 2019
Burden Reduction Price Transparency Regulatory

AMRPA Letter of Support for CONNECT for Health Act of 2019

November 25, 2019
Legislative Telehealth

AMRPA Response to CMS Request for Information on Medicare Program Integrity

November 20, 2019
Audits Medicare Advantage Prior Authorization Regulatory Traditional Medicare

AMRPA Submits Comments on CY 2020 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule

September 27, 2019
MIPS Physician Fee Schedule

AMRPA Responds to CMS’ Proposed Price Reporting Requirements in CY 2020 Hospital Outpatient PPS Proposed Rule

September 27, 2019
Price Transparency
Scroll to Top
Skip to content